A detailed history of Bessemer Group Inc transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 180 shares of COGT stock, worth $1,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares
180
Holding current value
$1,396
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$8.24 - $11.48 $1,483 - $2,066
180 New
180 $2,000
Q2 2022

Aug 10, 2022

SELL
$3.92 - $9.73 $1,105 - $2,743
-282 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$7.47 - $12.34 $2,106 - $3,479
282 New
282 $2,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $510M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.